About this Medicine article
A phase I clinical trial of recombinant human tumor necrosis factor given daily for five days by Patrick J. Creaven; Dean E. Brenner; J. Wayne Cowens; Robert P. Huben; Richard M. Wolf; Hiroshi Takita; Susan G. Arbuck; Mohamed S. Razack; April D. Proefrock is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Patrick J. Creaven; Dean E. Brenner; J. Wayne Cowens; Robert P. Huben; Richard M. Wolf; Hiroshi Takita; Susan G. Arbuck; Mohamed S. Razack; April D. Proefrock
- Publisher
- Springer; Springer-Verlag; Springer Verlag; Springer Science and Business Media LLC (ISSN 0344-5704)
- Published
- 1989
- Language
- EN
- Field
- Medicine (Health Sciences)